Preliminary program
More detailed program containing exact times and titles will be posted shortly
Session 1 - Metabolism and metabolomics in cancer and disease
Erik Knutsen - Opening remarks
Katja Benedikte Prestø Elgstøen
Veronika Pettersen
Torbjørn Myhre
Jack-Ansgar Bruun
Ole Kristian Greiner Tollersrud - The role of lysosomal metabolism in inflammation
Eelke Snoeren - The effects of junk food consumption on brain and behavior
Nelsy Taboko-Foncha
Session 2 - Combining basic and translational research
Piyapan Suwattananuruk - PET Imaging of the C-X-C Chemokine Receptor Type 4 in a Glioblastoma Animal Model using a Novel Ga-68-Labeled Tetrahydroquinoline radiotracer
Maria Therese Ahlen - Prophylactic treatment to avoid platelet alloimmunization in pregnant women: can we design antibody variants for a more favorable risk profile during pregnancy?
Synnøve Magnussen - Combining molecular analysis with a clinical case
Eduarda Guerreiro - Surface of extracellular vesicles from activated platelets are decorated with coagulation-associated proteins
Session 3 - From 2D to 3D, organoid, and organ-on-chip
Stefan Krauss
Harry Dawson - Generating real life like preclinical data with 3D organs on well: case studies on breast cancer and adipose tissue organoids, is biological complexity needed?
Merck
Zhe Xing and Jiazheng Cai - Advancing Cell Modeling: The Shift from 2D to 3D
Kajangi Gnanachandran - Studying the adverse effects of polypharmacy on liver sinusoidal endothelial cells (LSEC) in mouse liver-derived in vitro models: advancing from 2D to 3D systems
Bartlomiej Zapotoczny - Engineering the Liver Niche In Vitro: The Role of Soft Substrates in Culturing LSEC
Åsa Birna Birgisdottir - Exploiting cardiomyocytes derived from human induced pluripotent stem cells and engineered heart tissue for studying cellular mechanism in the human heart.
Hege Lynum Pedersen - From 2D to 3D culturing of renal proximal tubule epithelial cells (RPTEC)
Session 4 - Sustainable research and clinical practice
Ernst Ahlberg - AI decision making in pharmaceutical research
Huw Haugland-Grange - FAIR and "as open as possible": what does this mean in practice for your research data?
Elixir
VWR
Susannah von Hofsten - Embryonic development and EMT state are decisive for expression of the
proteoglycan core proteins in human tissue
Erik Knutsen - Closing remarks